Previous Close | 27.42 |
Open | 27.39 |
Bid | 25.70 |
Ask | 28.30 |
Strike | 390.00 |
Expire Date | 2023-09-15 |
Day's Range | 27.39 - 27.42 |
Contract Range | N/A |
Volume | |
Open Interest | 21 |
In this week's video, I cover everything you need to know about news related to Tesla (NASDAQ: TSLA) during the week of March 20. Today's video will focus on Tesla's continued domination in Europe and China, why the competition struggles to keep up, and Ford's new financial reporting.
Tesla did that to the automotive industry. CRISPR Therapeutics (NASDAQ: CRSP) potentially offers a new way to treat disease. Here is why CRISPR Therapeutics should at least be on your watch list today.
Analysts and investors have rightly focused on Tesla's core business thus far. Services includes Supercharger revenue, parts, and used car sales. Tesla's services segment brings in the most revenue other than EV sales.